INCEPTA VACCINE LTD CHANGED

Company Introduction:

Incepta Vaccine Ltd., based in Bangladesh, is a leading pharmaceutical company dedicated to the research, development, and manufacturing of a comprehensive range of human vaccines. As a key player in the global health sector, the company utilizes advanced technology and adheres to stringent international quality standards to produce high-quality, effective, and affordable vaccines. Incepta Vaccine Ltd. plays a vital role in disease prevention and control, supplying its products to both domestic markets and international organizations such as UNICEF and WHO. Its diverse portfolio includes vaccines for various infectious diseases, contributing significantly to global public health initiatives.

Business Type:

Factory (Manufacturer)

Incepta Vaccine Ltd, based in Bangladesh, manufactures and sells a diverse range of pharmaceutical products, primarily focusing on vaccines and other biological products. Their product portfolio includes:

Human Vaccines:

Diphtheria, Tetanus, Pertussis (DTwP and DTaP) vaccines

Hepatitis B vaccine

Tetanus Toxoid (TT) vaccine

Measles, Mumps, Rubella (MMR) vaccine

Oral Polio vaccine (OPV)

Inactivated Polio vaccine (IPV)

Typhoid conjugate vaccine

Cholera vaccine

Influenza vaccine

Rabies vaccine

Human Papillomavirus (HPV) vaccine

Meningococcal vaccine

Japanese Encephalitis vaccine

Varicella vaccine

Pneumococcal conjugate vaccine

Rotavirus vaccine

Other Pharmaceutical Products:

Incepta also produces a wide array of non-vaccine pharmaceutical products across various therapeutic areas, including but not limited to antibiotics, anti-ulcerants, analgesics, anti-diabetics, cardiovascular drugs, respiratory drugs, central nervous system drugs, dermatological preparations, and vitamins and minerals. However, their vaccine division is particularly prominent.